These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 34093827)
1. Development and Validation of an Immune-Related Long Non-coding RNA Prognostic Model in Glioma. Qiu X; Tian Y; Xu J; Jiang X; Liu Z; Qi X; Chang X; Zhao J; Huang J J Cancer; 2021; 12(14):4264-4276. PubMed ID: 34093827 [No Abstract] [Full Text] [Related]
2. Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinoma. Jiang Y; Gou X; Wei Z; Tan J; Yu H; Zhou X; Li X Cancer Cell Int; 2020; 20():166. PubMed ID: 32435157 [TBL] [Abstract][Full Text] [Related]
3. Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma. Liu Y; Gou X; Wei Z; Yu H; Zhou X; Li X Aging (Albany NY); 2020 Jul; 12(15):15359-15373. PubMed ID: 32716909 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA. Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543 [TBL] [Abstract][Full Text] [Related]
5. Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma. Huang K; Yue X; Zheng Y; Zhang Z; Cheng M; Li L; Chen Z; Yang Z; Bian E; Zhao B Front Oncol; 2021; 11():726745. PubMed ID: 34540695 [TBL] [Abstract][Full Text] [Related]
6. Identification of a cellular senescence-related-lncRNA (SRlncRNA) signature to predict the overall survival of glioma patients and the tumor immune microenvironment. Liu Q; Bao H; Zhang S; Song T; Li C; Sun G; Sun X; Fu T; Wang Y; Liang P Front Genet; 2023; 14():1096792. PubMed ID: 36911393 [No Abstract] [Full Text] [Related]
7. An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients. Xia P; Li Q; Wu G; Huang Y Cell Mol Neurobiol; 2021 Mar; 41(2):365-375. PubMed ID: 32410107 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer. Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791 [TBL] [Abstract][Full Text] [Related]
9. Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs. Wen J; Wang Y; Luo L; Peng L; Chen C; Guo J; Ge Y; Li W; Jin X Front Oncol; 2020; 10():578809. PubMed ID: 33330055 [TBL] [Abstract][Full Text] [Related]
10. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Li W; Liu J; Zhao H Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896 [TBL] [Abstract][Full Text] [Related]
11. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma. Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A Front Genet; 2021; 12():718717. PubMed ID: 34925438 [No Abstract] [Full Text] [Related]
12. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma. Zhao J; Wang L; Wei B Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843 [TBL] [Abstract][Full Text] [Related]
13. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis. Zhang C; Liu H; Xu P; Tan Y; Xu Y; Wang L; Liu B; Chen Q; Tian D BMC Cancer; 2021 Mar; 21(1):251. PubMed ID: 33750353 [TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of Immune-Related lncRNA Signature as a Prognostic Model for Skin Cutaneous Melanoma. Ping S; Wang S; He J; Chen J Pharmgenomics Pers Med; 2021; 14():667-681. PubMed ID: 34113151 [TBL] [Abstract][Full Text] [Related]
15. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer. Ping L; Zhang K; Ou X; Qiu X; Xiao X Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734 [No Abstract] [Full Text] [Related]
16. An Immune-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial Cancer. Wang Z; Liu Y; Zhang J; Zhao R; Zhou X; Wang H J Oncol; 2021; 2021():9972454. PubMed ID: 34925511 [TBL] [Abstract][Full Text] [Related]
17. A novel signature based on necroptosis-related long non-coding RNAs for predicting prognosis of patients with glioma. Xia P; Huang Y; Chen G Front Oncol; 2022; 12():940220. PubMed ID: 36033510 [TBL] [Abstract][Full Text] [Related]
18. Development of an Immune-Related LncRNA Prognostic Signature for Glioma. Cao Y; Zhu H; Tan J; Yin W; Zhou Q; Xin Z; Wu Z; Jiang Z; Guo Y; Kuang Y; Li C; Zhao M; Jiang X; Peng J; Ren C Front Genet; 2021; 12():678436. PubMed ID: 34194477 [TBL] [Abstract][Full Text] [Related]
19. Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma. Liang Q; Guan G; Li X; Wei C; Wu J; Cheng P; Wu A; Cheng W J Transl Med; 2020 Oct; 18(1):378. PubMed ID: 33028341 [TBL] [Abstract][Full Text] [Related]
20. Identification of a Glycolysis-Related LncRNA Signature to Predict Survival in Diffuse Glioma Patients. Wang Y; Zhou W; Ma S; Guan X; Zhang D; Peng J; Wang X; Yuan L; Li P; Mao B; Kang P; Li D; Zhang C; Jia W Front Oncol; 2020; 10():597877. PubMed ID: 33614485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]